Actively Recruiting
Safety and Early Effectiveness of ARC-IM Therapy Using Epidural Electrical Stimulation to Manage Blood Pressure in Parkinsons Disease
Led by Ecole Polytechnique Fédérale de Lausanne · Updated on 2026-07-07
5
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and early effectiveness of ARC-IM Therapy, which involves epidural electrical stimulation, to help manage blood pressure in people with typical or atypical Parkinsons Disease who experience orthostatic hypotension. This study aims to support better hemodynamic control in this population and is sponsored by Ecole Polytechnique Fdrale de Lausanne. Participants will receive the ARC-IM Investigational System, which includes implantation of a stimulation lead on the lower thoracic spinal cord and a neurostimulator in the abdominal area. All participants will use this implantable device during the study, with no placebo or comparison group. The therapys configuration and effects will be monitored over time. During the study, participants will undergo various tests and assessments including orthostatic head-up tilt tests, symptom questionnaires, mobility and balance tests, and user satisfaction surveys at set intervals after therapy configuration. Researchers will track device safety throughout the study, which may last up to five years. Participants will attend scheduled visits to evaluate therapy usability and monitor health outcomes.
CONDITIONS
Brief Title
Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease
Research Team
G
Gregoire Courtine, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here